SEARCH
Natrium Capital Logo
menu


All News Entries

Natrium Advises Solvay on Sale of its North American and European Amphoteric Surfactant Business to OpenGate Capital

5 Jan 2021

Natrium Capital News

Natrium Capital Limited is pleased to announce it has advised Solvay S.A (“Solvay”) on the sale of its North American and European amphoteric surfactant business to OpenGate Capital (“OpenGate”).

The sale includes the three main production sites supporting the amphoteric product lines located in University Park (Illinois, USA), Genthin (Germany), Halifax (United Kingdom), and a tolling business in Turkey. The agreement also includes tolling and service agreements between Solvay and OpenGate to ensure a seamless transition and minimal customer disruption.

The acquisition is expected to close by the end of Q1 2021 pending completion of all required social dialogues and regulatory approvals.

Natrium Capital Limited acted as sole financial advisor to Solvay in connection with this transaction.

About Solvay

Solvay is a science company whose technologies bring benefits to many aspects of daily life. With more than 24,100 employees in 64 countries, Solvay bonds people, ideas and elements to reinvent progress. The Group seeks to create sustainable shared value for all, notably through its Solvay One Planet plan crafted around three pillars: protecting the climate, preserving resources and fostering better life. The Group’s innovative solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices, health care applications, water and air purification systems. Founded in 1863, Solvay today ranks among the world’s top three companies for the vast majority of its activities and delivered net sales of €10.2 billion in 2019. Solvay is listed on Euronext Brussels (SOLB) and Paris and in the United States, where its shares (SOLVY) are traded through a Level I ADR program. Find more information at www.solvay.com.

About Natrium Capital

Natrium Capital is a corporate finance boutique specialising in the chemical, material, biotechnology, and clean technology industries. Natrium Capital offers high level strategic and M&A (Mergers and Acquisitions) execution advice and has a wealth of experience in investment banking and corporate finance. Natrium Capital advises clients in Europe, North America, Latin America, and Asia, especially India. Natrium Capital was set up by Alasdair Nisbet in 2012. Find more information at www.natriumcapital.com.

“… over $100bn of transactions over the last twenty years”